Correlation of platelet reactivity and C-reactive protein levels to occurrence of peri-procedural myocardial infarction in patients undergoing percutaneous coronary intervention (from the ARMYDA-CRP Study)

American Journal of Cardiology

Volumn 111, Issue 12, 2013, Pages 1739-1744

  Patti, Giuseppe ^a   Mangiacapra, Fabio ^a   Ricottini, Elisabetta ^a   Cannatà, Antonio ^a   Cavallari, Ilaria ^a   Vizzi, Vincenzo ^a   D'Ambrosio, Andrea ^a   Dicuonzo, Giordano ^a   Di Sciascio, Germano ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CLOPIDOGREL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CARDIAC PATIENT; CONFIDENCE INTERVAL; FEMALE; HEART INFARCTION; HUMAN; INCIDENCE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; POINT OF CARE TESTING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84878849994     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.02.028     Document Type: Article

References (30)

1. M.J. Price, S. Endemann, R.R. Gollapudi, R. Valencia, C.T. Stinis, J.P. Levisay, A. Ernst, N.S. Sawhney, R.A. Schatz, and P.S. Teirstein Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation Eur Heart J 29 2008 992 1000
2. R. Marcucci, A.M. Gori, R. Paniccia, B. Giusti, S. Valente, C. Giglioli, P. Buonamici, D. Antoniucci, R. Abbate, and G.F. Gensini Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up Circulation 119 2009 237 242
3. G. Patti, A. Nusca, F. Mangiacapra, L. Gatto, A. D'Ambrosio, and G. Di Sciascio Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Platelet Reactivity Predicts Outcome) study J Am Coll Cardiol 52 2008 1128 1133
4. G. Patti, V. Pasceri, V. Vizzi, E. Ricottini, and G. Di Sciascio Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-BLEEDing study) Am J Cardiol 107 2011 995 1000
5. S.S. Brar, J. ten Berg, R. Marcucci, M.J. Price, M. Valgimigli, H.S. Kim, G. Patti, N.J. Breet, G. DiSciascio, T. Cuisset, and G. Dangas Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data J Am Coll Cardiol 58 2011 1945 1954
6. D.W. Park, S.W. Lee, S.C. Yun, H.G. Song, J.M. Ahn, J.Y. Lee, W.J. Kim, S.J. Kang, Y.H. Kim, C.W. Lee, S.W. Park, and S.J. Park A point-of-care platelet function assay and C-reactive protein for prediction of major cardiovascular events after drug-eluting stent implantation J Am Coll Cardiol 58 2011 2630 2639
7. D.W. Park, S.C. Yun, J.Y. Lee, W.J. Kim, S.J. Kang, S.W. Lee, Y.H. Kim, C.W. Lee, J.J. Kim, S.W. Park, and S.J. Park C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation Circulation 120 2009 1987 1995
8. 12 cartridge for monitoring platelet inhibition with clopidogrel Methods Find Exp Clin Pharmacol 28 2006 315 322
9. K. Thygesen, J.S. Alpert, H.D. White Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction Universal definition of myocardial infarction J Am Coll Cardiol 50 2007 2173 2195
10. A. Prasad, B.J. Gersh, M.E. Bertrand, A.M. Lincoff, J.W. Moses, E.M. Ohman, H.D. White, S.J. Pocock, B.T. McLaurin, D.A. Cox, A.J. Lansky, R. Mehran, and G.W. Stone Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial J Am Coll Cardiol 54 2009 477 486
11. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
12. F. Mangiacapra, E. Barbato, G. Patti, L. Gatto, V. Vizzi, E. Ricottini, A. D'Ambrosio, W. Wijns, and G. Di Sciascio Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention JACC Cardiovasc Interv 3 2010 318 323
13. G. Patti, G. Di Sciascio, A. D'Ambrosio, G. Dicuonzo, A. Abbate, and A. Dobrina Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention Am J Cardiol 89 2002 372 376
14. A. Buffon, G. Liuzzo, L.M. Biasucci, P. Pasqualetti, V. Ramazzotti, A.G. Rebuzzi, F. Crea, and A. Maseri Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty J Am Coll Cardiol 34 1999 1512 1521
15. A. Gaspardone, F. Crea, F. Versaci, F. Tomai, A. Pellegrino, L. Chiariello, and P.A. Gioffrè Predictive value of C-reactive protein after successful coronary artery stenting in patients with stable angina Am J Cardiol 82 1998 515 518
16. A. Goldberg, L. Gruberg, A. Roguin, S. Petcherski, D. Rimer, W. Markiewicz, R. Beyar, and D. Aronson Preprocedural C-reactive protein levels predict myocardial necrosis after successful coronary stenting in patients with stable angina Am Heart J 151 2006 1265 1270
17. C. Heeschen, C.W. Hamm, J. Bruemmer, M.L. Simoons CAPTURE Investigators Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis J Am Coll Cardiol 35 2000 1535 1542
18. G. Patti, M. Chello, V. Pasceri, D. Colonna, A. Nusca, M. Miglionico, A. D'Ambrosio, E. Covino, and G. Di Sciascio Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of Myocardial Damage During Angioplasty-Cell Adhesion Molecules) substudy J Am Coll Cardiol 48 2006 1560 1566
19. H.D. Danenberg, A.J. Szalai, R.V. Swaminathan, L. Peng, Z. Chen, P. Seifert, W.P. Fay, D.I. Simon, and E.R. Edelman Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice Circulation 108 2003 512 515
20. R.J. Bisoendial, J.J. Kastelein, J.H. Levels, J.J. Zwaginga, B. van den Bogaard, P.H. Reitsma, J.C. Meijers, D. Hartman, M. Levi, and E.S. Stroes Activation of inflammation and coagulation after infusion of C-reactive protein in humans Circ Res 96 2005 714 716
21. V. Pasceri, J.T. Willerson, and E.T. Yeh Direct proinflammatory effect of C-reactive protein on human endothelial cells Circulation 102 2000 2165 2168
22. A. Sestito, G.A. Sgueglia, A. Spinelli, E.P. Navarese, F. Infusino, F. Crea, and A.G. Lanza Increased platelet reactivity in unstable angina patients is not related to C-reactive protein levels Platelets 17 2006 336 339
23. K.M. Akkerhuis, J.H. Alexander, B.E. Tardiff, E. Boersma, R.A. Harrington, A.M. Lincoff, and M.L. Simoons Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? Circulation 105 2002 554 556
24. J.P.A. Ioannidis, E. Karvouni, and D.G. Katritis Mortality risk conferred by small elevations of creatine-kinase MB isoenzyme after percutaneous intervention J Am Coll Cardiol 42 2003 1406 1411
25. G. Patti, C.P. Cannon, S.A. Murphy, S. Mega, V. Pasceri, C. Briguori, A. Colombo, K.H. Yun, M.H. Jeong, J.S. Kim, D. Choi, H. Bozbas, M. Kinoshita, K. Fukuda, X.W. Jia, H. Hara, S. Cay, and G. Di Sciascio Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies Circulation 123 2011 1622 1632
26. G. Patti, V. Pasceri, G. Colonna, M. Miglionico, D. Fischetti, G. Sardella, A. Montinaro, and G. Di Sciascio Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial J Am Coll Cardiol 49 2007 1272 1278
27. G. Patti, G. Colonna, V. Pasceri, L.L. Pepe, A. Montinaro, and G. Di Sciascio Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty) study Circulation 111 2005 2099 2106
28. G. Patti, D. Grieco, G. Dicuonzo, V. Pasceri, A. Nusca, and G. Di Sciascio High versus standard clopidogrel maintenance dose after percutaneous coronary intervention: effects on platelet inhibition, endothelial function and inflammation. Results of the ARMYDA-150 mg (Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty) randomized study J Am Coll Cardiol 57 2011 771 778
29. J.B. Muhlestein Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients Thromb Haemost 103 2010 71 82
30. G. Di Sciascio, G. Patti, V. Pasceri, A. Gaspardone, G. Colonna, and A. Montinaro Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) randomized trial J Am Coll Cardiol 54 2009 558 565